From cereal to food giant — Kellogg stages a makeover

From cereal to food giant — Kellogg stages a makeover


Kellogg, the 117-year-old brand that started as a breakfast cereal company has since expanded to be one of the largest food companies in the world, has seen declining cereal sales over the past couple of decades.

The one-time category leader is now facing a number of setbacks, including numerous lawsuits over its products’ nutritional value amid a more health-conscious consumer base. And in 2021, the food giant sustained a damaging fire at its Memphis facility, and later that same year 1,400 workers went on strike to demand better pay and enhanced benefits. Workers eventually ended the three-month strike and agreed to a new contract in December, which included a $1.10 per hour raise for all employees.

In an effort to stimulate growth, on June 21, 2022, the company announced plans to split into three separate companies.

“Right now is the opportune time to do this. We are coming from a position of real strength and great momentum. We have completely turned the business around from a top-line and bottom-line perspective. And we see the next step in our potential in unlocking three new companies,” said Kellogg CEO Steve Cahillane.

Watch the video to learn more about Kellogg’s move to split the company in order to try to kickstart cereal sales and regain some of its bygone glory.



Source

Nike cuts 1,400 roles in second round of layoffs this year
Business

Nike cuts 1,400 roles in second round of layoffs this year

People walk past a Nike store in New York City, on April 2, 2025. Kylie Cooper | Reuters Nike announced a new round of layoffs on Thursday impacting approximately 1,400 roles across the organization, mostly concentrated in its technology department. In a note from COO Venkatesh Alagirisamy, the company said the layoffs were part of […]

Read More
Trump administration moves to reclassify cannabis in major shift that could expand research
Business

Trump administration moves to reclassify cannabis in major shift that could expand research

The Trump administration moved Thursday to reclassify cannabis under federal law, which could significantly expand scientific research into the drug’s medical uses. The change would not legalize the drug at the federal level, but shift cannabis from its current status as a Schedule I substance to Schedule III under the U.S. Drug Enforcement Administration’s controlled […]

Read More
Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free
Business

Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

U.S. President Donald Trump (C) speaks during an event on advancing health care affordability in the Oval Office of the White House on April 23, 2026 in Washington, DC. Alex Wong | Getty Images Regeneron agreed to lower U.S. drug prices for some Americans as part of a deal with President Donald Trump, the White […]

Read More